Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP Trial for chronic suppurative otitis media
PACTR202609866048204Phase 1Not yet recruiting
- Sponsor
- ZAMBART
- Start
- Sep 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of povidone-iodine, ciprofloxacin and saline in chronic suppurative otitis media (CSOM) (3 arms), sponsored by ZAMBART. Primary endpoint: Dry ear by week 2. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
povidone-iodineciprofloxacinsaline
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on PACTR202609866048204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609866048204.